Skip to main content
OPTUS Pharmaceutical Co., Ltd. logo

OPTUS Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 131030 ISIN · KR7131030009 KO Manufacturing
Filings indexed 159 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 131030

About OPTUS Pharmaceutical Co., Ltd.

http://optuspharm.com/us/main/index.php

OPTUS Pharmaceutical Co., Ltd. is a specialized pharmaceutical company focused on the research, development, manufacturing, and commercialization of ophthalmic products. The company's primary expertise lies in producing sterile, preservative-free, single-dose (unit-dose) formulations. Its therapeutic portfolio addresses conditions such as dry eye syndrome, keratoconjunctival epithelial disease, bacterial conjunctivitis, and glaucoma. In addition to prescription and over-the-counter pharmaceuticals, the company is expanding into a total eye care model through its OUE& brand, which encompasses nutritional supplements (OUEFIT) and cosmeceuticals (OUELAB). The company operates EU-GMP certified manufacturing facilities and distributes its products globally.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 92% confidence The document is titled “분기보고서 (제17기) 2026년 01월 01일~2026년 03월 31일” and provides a full quarterly report for Optus Pharmaceuticals, including detailed company overview, share capital changes, self-share transactions, business history, and other substantive financial and governance tables. It is not merely an announcement or a summary but the actual Interim/Quarterly Report. Therefore, it should be classified as IR (Interim / Quarterly Report). Q1 2026
2026-05-15 Korean
불성실공시법인지정예고 (공시변경)
Regulatory Filings Classification · 95% confidence The document is a regulatory compliance announcement in Korean detailing the advance notice of designation as an unreliable disclosure corporation, including dates, penalty points, and relevant rules. It contains no financial statements or management commentary but is a public disclosure required by exchange regulations. This falls under general regulatory filings.
2026-05-14 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 95% confidence The document is a Korean "자기주식처분결과보고서" (treasury share disposal result report) filed to the Financial Supervisory Service, detailing the sale of the company's own shares (dates, quantities, prices, remaining treasury shares). This is clearly a report of a transaction in the company’s own shares. Therefore, it matches the “Transaction in Own Shares” category (Code: POS).
2026-04-15 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 91% confidence The document is a ‘주요사항보고서(자기주식 처분 결정)’ detailing the decision to dispose of treasury shares (number of shares, disposal price, period, purpose, counterparties, price calculation, dilution effect, etc.). This is not an annual or interim report but a corporate action announcement regarding the sale of its own shares. According to the category definitions, it best fits “Transaction in Own Shares” (POS).
2026-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 90% confidence The document is a formal notification to the Financial Supervisory Service/Korea Exchange regarding the appointment and dismissal of outside directors (“사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고”). It provides details about board composition changes, effective dates, and reasons. This matches the definition for Board/Management Information (MANG): announcements of changes in the company’s board of directors or senior management.
2026-03-25 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled “정기주주총회결과” (Annual General Meeting results) and provides detailed voting outcomes, approval percentages, and resolutions on AGM agenda items (financial statements approval, director elections, dividend resolutions, share repurchase plan, etc.). This matches the category for official results from shareholder votes at a general meeting.
2026-03-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.